Neuromuscular transmission electrode/sensor lead
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
03-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
GE Healthcare Australia Pty Ltd
Class:
Class IIa
Manufactured by:
GE Healthcare Finland Oy Kuortaneenkatu 2, Helsinki, FI-00510 Finland
Therapeutic area:
59690 - Neuromuscular transmission electrode/sensor lead
Therapeutic indications:
This device is intended to be non-sterile insulated metal wire(s) designed to conduct electrical signals between neuromuscular transmission (NMT) electrodes and sensors placed on a patient's body and a patient monitoring system module, intended for the monitoring of patient relaxation to determine the level of neuromuscular block and the localization of a nerve in an area of the body. This is a reusable device.
Authorization status:
A
Authorization date:
2017-04-27
